Cytiva-Banner-800x220
Cytiva-Banner-800x220

Projects

The pharmaceutical projects listed in this section are those that are announced from time to time around the world

FUJIFILM Invests £400M to Expand Biomanufacturing and Process Development Capacity

FUJIFILM Biotechnologies, a global contract development and manufacturing organisation CDMO for biologics, vaccines, and advanced therapies, has expanded its site in Teesside, UK, with a total investment

Lilly Announces New $3.5B Injectable Manufacturing Facility in Pennsylvania

Eli Lilly and Company has announced plans to invest more than $35 billion in a new injectable medicine and device manufacturing facility in the Lehigh Valley, Pennsylvania The site will support the production

Novartis Strengthens Radioligand Therapy Supply in U.S. with $23B Investment

Novartis has announced plans to construct its fourth radioligand therapy RLT manufacturing facility in Winter Park, Florida This purposebuilt, 35,000squarefoot facility is part of the companys $23 billion US investment programme

Genentech Expands Holly Springs Operations with $2B Investment

Genentech has more than doubled its investment in a new biomanufacturing facility in Holly Springs, North Carolina, bringing the total commitment to around $2 billion The expansion forms part of Roche and Genentechs $50 billion investment

Sharp Sterile Manufacturing Announces $28M Investment to Expand Lee Facility

Sharp Sterile Manufacturing has announced a $28 million expansion of its Lee, Massachusetts site, aiming to increase production capacity and support local skilled jobs in the life sciences sector

Alnylam Plans Major $250M Manufacturing Facility Expansion in Massachusetts

Alnylam Pharmaceuticals has announced a $250 million investment to expand its advanced manufacturing site in Norton, Massachusetts The project will add a new enzymatic ligation platform to support the growing global demand for RNA interference RNAi therapies The expansion will strengthen Alnylams

Lilly Expands U.S. Operations with $6 Billion Huntsville Manufacturing Facility

Eli Lilly and Company NYSE LLY has announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama The facility will focus on producing active pharmaceutical ingredients APIs

Novartis Expands U.S. Footprint with $23B North Carolina Manufacturing Hub

Novartis has announced plans to establish a new flagship manufacturing hub in North Carolina, part of a broader $23 billion investment in USbased infrastructure The expansion will centralise production

Sharp Services Invests $100M to Expand U.S. & European Manufacturing Capabilities

Sharp Services has committed $100 million to expand capacity and enhance services across its global pharmaceutical network This programme is designed to support growing demand for clinical and commercial medicines

ACG Invests $200 Million to Expand New Capsule Manufacturing Facility in Atlanta

ACG, one of the worlds leading providers of integrated soliddosage solutions, has announced a $200 million phased investment to set up its first empty capsule manufacturing operations in the United States